PMC:7324763 / 77047-77682
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1240 | 0-5 | CHEBI:35472;CHEBI:35472 | denotes | NSAID |
| T1241 | 84-90 | UBERON:0002405;GO:0006955 | denotes | immune |
| T1242 | 91-100 | GO:0006955 | denotes | responses |
| T1243 | 124-134 | GO:0042571 | denotes | antibodies |
| T1244 | 141-150 | CHEBI:5855;CHEBI:5855 | denotes | ibuprofen |
| T1245 | 210-219 | CHEBI:5855;CHEBI:5855 | denotes | ibuprofen |
| T1246 | 254-264 | GO:0010467 | denotes | expression |
| T1247 | 272-276 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T1248 | 315-325 | SP_7 | denotes | SARS-CoV-2 |
| T1249 | 326-331 | NCBITaxon:10239;GO:0035376 | denotes | viral |
| T1250 | 332-337 | GO:0035376 | denotes | entry |
| T1251 | 417-425 | SP_7 | denotes | COVID-19 |
| T1252 | 451-460 | CHEBI:5855;CHEBI:5855 | denotes | ibuprofen |
| T1253 | 470-476 | CHEBI:35472;CHEBI:35472 | denotes | NSAIDs |
| T1254 | 545-550 | PR:000000017 | denotes | IFN-γ |
| T1255 | 555-560 | PR:000000134;GO:0032640 | denotes | TNF-α |
| T1256 | 561-571 | GO:0032640 | denotes | production |
| T1257 | 617-625 | SP_7 | denotes | COVID-19 |
| T47072 | 0-5 | CHEBI:35472;CHEBI:35472 | denotes | NSAID |
| T70483 | 84-90 | UBERON:0002405;GO:0006955 | denotes | immune |
| T5444 | 91-100 | GO:0006955 | denotes | responses |
| T46572 | 124-134 | GO:0042571 | denotes | antibodies |
| T16119 | 141-150 | CHEBI:5855;CHEBI:5855 | denotes | ibuprofen |
| T35977 | 210-219 | CHEBI:5855;CHEBI:5855 | denotes | ibuprofen |
| T46174 | 254-264 | GO:0010467 | denotes | expression |
| T58823 | 272-276 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T10504 | 315-325 | SP_7 | denotes | SARS-CoV-2 |
| T61782 | 326-331 | NCBITaxon:10239;GO:0035376 | denotes | viral |
| T47807 | 332-337 | GO:0035376 | denotes | entry |
| T12613 | 417-425 | SP_7 | denotes | COVID-19 |
| T40182 | 451-460 | CHEBI:5855;CHEBI:5855 | denotes | ibuprofen |
| T89863 | 470-476 | CHEBI:35472;CHEBI:35472 | denotes | NSAIDs |
| T60778 | 545-550 | PR:000000017 | denotes | IFN-γ |
| T93145 | 555-560 | PR:000000134;GO:0032640 | denotes | TNF-α |
| T95675 | 561-571 | GO:0032640 | denotes | production |
| T36464 | 617-625 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T875 | 537-544 | Body_part | denotes | NK cell | http://purl.org/sig/ont/fma/fma63147 |
| T876 | 540-544 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T538 | 315-323 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T539 | 315-319 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T540 | 417-425 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T541 | 617-625 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T918 | 220-223 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T919 | 506-507 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T920 | 537-544 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cell |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T72788 | 0-5 | Chemical | denotes | NSAID | http://purl.obolibrary.org/obo/CHEBI_35475 |
| T203 | 141-150 | Chemical | denotes | ibuprofen | http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855 |
| T33962 | 210-219 | Chemical | denotes | ibuprofen | http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855 |
| T73535 | 451-460 | Chemical | denotes | ibuprofen | http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855 |
| T209 | 470-476 | Chemical | denotes | NSAIDs | http://purl.obolibrary.org/obo/CHEBI_35475 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2168 | 272-276 | Gene | denotes | ACE2 | Gene:59272 |
| 2169 | 545-550 | Gene | denotes | IFN-γ | Gene:3458 |
| 2170 | 555-560 | Gene | denotes | TNF-α | Gene:7124 |
| 2171 | 315-325 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2172 | 626-634 | Species | denotes | patients | Tax:9606 |
| 2173 | 141-150 | Chemical | denotes | ibuprofen | MESH:D007052 |
| 2174 | 210-219 | Chemical | denotes | ibuprofen | MESH:D007052 |
| 2175 | 451-460 | Chemical | denotes | ibuprofen | MESH:D007052 |
| 2176 | 417-425 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2177 | 617-625 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T181 | 84-100 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
MyTest
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32655581-19345936-34771861 | 191-194 | 19345936 | denotes | 266 |
| 32655581-32171062-34771862 | 287-290 | 32171062 | denotes | 267 |
| 32655581-17083365-34771863 | 573-576 | 17083365 | denotes | 268 |
TEST0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32655581-191-198-3171434 | 191-194 | ["19345936"] | denotes | 266 |
| 32655581-90-97-3171435 | 287-290 | ["32171062"] | denotes | 267 |
| 32655581-103-110-3171436 | 573-576 | ["17083365"] | denotes | 268 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32655581-19345936-34771861 | 191-194 | 19345936 | denotes | 266 |
| 32655581-32171062-34771862 | 287-290 | 32171062 | denotes | 267 |
| 32655581-17083365-34771863 | 573-576 | 17083365 | denotes | 268 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T466 | 0-196 | Sentence | denotes | NSAID therapy should be used with caution as they have been shown to interfere with immune responses and ability to produce antibodies, with ibuprofen having the greatest suppressive effect (266). |
| T467 | 197-338 | Sentence | denotes | Furthermore, ibuprofen has been reported to increase the expression of the ACE2 receptor (267) which could facilitate SARS-CoV-2 viral entry. |
| T468 | 339-469 | Sentence | denotes | This finding should be considered for any current (NCT04334629) and potential COVID-19 clinical trial assessing ibuprofen therapy. |
| T469 | 470-635 | Sentence | denotes | NSAIDs also have been shown to have a direct suppressive effect on NK cell IFN-γ and TNF-α production (268) which may be beneficial for late stage COVID-19 patients. |